Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Radiation-induced Vascular Damage and the Impact on the Treatment Outcome of Stereotactic Body Radiotherapy.

Lindblom EK, Hui S, Brooks J, Dasu A, Kujawski M, Toma-Dasu I.

Anticancer Res. 2019 Jun;39(6):2721-2727. doi: 10.21873/anticanres.13398.

PMID:
31177107
2.

Pilot study of totally thoracoscopic periareolar approach for minimally invasive mitral valve surgery. Towards even less invasive?

Maruszewski M, Smoczyński R, Kowalewski M, Bartczak M, Witkowska A, Staromłyński J, Drobiński D, Kujawski M, Suwalski P.

Wideochir Inne Tech Maloinwazyjne. 2019 Apr;14(2):326-332. doi: 10.5114/wiitm.2019.81663. Epub 2019 Jan 22.

3.

Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis.

Ramakrishna C, Kujawski M, Chu H, Li L, Mazmanian SK, Cantin EM.

Nat Commun. 2019 May 14;10(1):2153. doi: 10.1038/s41467-019-09884-6.

4.

CEACAM1 regulates the IL-6 mediated fever response to LPS through the RP105 receptor in murine monocytes.

Zhang Z, La Placa D, Nguyen T, Kujawski M, Le K, Li L, Shively JE.

BMC Immunol. 2019 Jan 23;20(1):7. doi: 10.1186/s12865-019-0287-y.

5.

CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.

Herrmann A, Priceman SJ, Swiderski P, Kujawski M, Xin H, Cherryholmes GA, Zhang W, Zhang C, Lahtz C, Kowolik C, Forman SJ, Kortylewski M, Yu H.

J Clin Invest. 2015 Jun;125(6):2547. doi: 10.1172/JCI82555. Epub 2015 Jun 1. No abstract available.

6.

Carbamates: A study on genotoxic, cytotoxic, and apoptotic effects induced in Chinese hamster ovary (CHO-K1) cells.

Soloneski S, Kujawski M, Scuto A, Larramendy ML.

Toxicol In Vitro. 2015 Aug;29(5):834-44. doi: 10.1016/j.tiv.2015.03.011. Epub 2015 Mar 24.

PMID:
25820133
7.

CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.

Herrmann A, Priceman SJ, Swiderski P, Kujawski M, Xin H, Cherryholmes GA, Zhang W, Zhang C, Lahtz C, Kowolik C, Forman SJ, Kortylewski M, Yu H.

J Clin Invest. 2014 Jul;124(7):2977-87. doi: 10.1172/JCI73174. Epub 2014 Jun 2. Erratum in: J Clin Invest. 2015 Jun;125(6):2547. Swiderski, Piotr [Added].

8.
9.

S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3.

Priceman SJ, Shen S, Wang L, Deng J, Yue C, Kujawski M, Yu H.

Cell Rep. 2014 Mar 27;6(6):992-999. doi: 10.1016/j.celrep.2014.02.016. Epub 2014 Mar 13.

10.

Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance.

Priceman SJ, Kujawski M, Shen S, Cherryholmes GA, Lee H, Zhang C, Kruper L, Mortimer J, Jove R, Riggs AD, Yu H.

Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13079-84. doi: 10.1073/pnas.1311557110. Epub 2013 Jul 22.

11.

SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-κB/STAT3 complex to its promoter in malignant lymphoid cells.

Scuto A, Kirschbaum M, Buettner R, Kujawski M, Cermak JM, Atadja P, Jove R.

Cell Death Dis. 2013 May 16;4:e635. doi: 10.1038/cddis.2013.159.

12.

DNA damage kinetics and apoptosis in ivermectin-treated Chinese hamster ovary cells.

Molinari G, Kujawski M, Scuto A, Soloneski S, Larramendy ML.

J Appl Toxicol. 2013 Nov;33(11):1260-7. doi: 10.1002/jat.2782. Epub 2012 Sep 7.

PMID:
22961421
13.

S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.

Deng J, Liu Y, Lee H, Herrmann A, Zhang W, Zhang C, Shen S, Priceman SJ, Kujawski M, Pal SK, Raubitschek A, Hoon DS, Forman S, Figlin RA, Liu J, Jove R, Yu H.

Cancer Cell. 2012 May 15;21(5):642-54. doi: 10.1016/j.ccr.2012.03.039.

14.

Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1.

Lu R, Kujawski M, Pan H, Shively JE.

Cancer Res. 2012 May 1;72(9):2239-50. doi: 10.1158/0008-5472.CAN-11-3016. Epub 2012 Mar 9. Erratum in: Cancer Res. 2016 Feb 15;76(4):984-5.

15.

STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma.

Scuto A, Kujawski M, Kowolik C, Krymskaya L, Wang L, Weiss LM, Digiusto D, Yu H, Forman S, Jove R.

Cancer Res. 2011 May 1;71(9):3182-8. doi: 10.1158/0008-5472.CAN-10-2380. Epub 2011 Apr 26.

16.

The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival.

Scuto A, Krejci P, Popplewell L, Wu J, Wang Y, Kujawski M, Kowolik C, Xin H, Chen L, Wang Y, Kretzner L, Yu H, Wilcox WR, Yen Y, Forman S, Jove R.

Leukemia. 2011 Mar;25(3):538-50. doi: 10.1038/leu.2010.289. Epub 2010 Dec 17.

17.

Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.

Kujawski M, Zhang C, Herrmann A, Reckamp K, Scuto A, Jensen M, Deng J, Forman S, Figlin R, Yu H.

Cancer Res. 2010 Dec 1;70(23):9599-610. doi: 10.1158/0008-5472.CAN-10-1293. Epub 2010 Nov 30.

18.

STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.

Lee H, Deng J, Kujawski M, Yang C, Liu Y, Herrmann A, Kortylewski M, Horne D, Somlo G, Forman S, Jove R, Yu H.

Nat Med. 2010 Dec;16(12):1421-8. doi: 10.1038/nm.2250. Epub 2010 Nov 21.

19.

Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells.

Herrmann A, Kortylewski M, Kujawski M, Zhang C, Reckamp K, Armstrong B, Wang L, Kowolik C, Deng J, Figlin R, Yu H.

Cancer Res. 2010 Oct 1;70(19):7455-64. doi: 10.1158/0008-5472.CAN-10-0736. Epub 2010 Sep 14.

20.

Antitumor activity of targeting SRC kinases in endothelial and myeloid cell compartments of the tumor microenvironment.

Liang W, Kujawski M, Wu J, Lu J, Herrmann A, Loera S, Yen Y, Lee F, Yu H, Wen W, Jove R.

Clin Cancer Res. 2010 Feb 1;16(3):924-35. doi: 10.1158/1078-0432.CCR-09-1486. Epub 2010 Jan 26.

21.

In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses.

Kortylewski M, Swiderski P, Herrmann A, Wang L, Kowolik C, Kujawski M, Lee H, Scuto A, Liu Y, Yang C, Deng J, Soifer HS, Raubitschek A, Forman S, Rossi JJ, Pardoll DM, Jove R, Yu H.

Nat Biotechnol. 2009 Oct;27(10):925-32. doi: 10.1038/nbt.1564. Epub 2009 Sep 13.

22.

Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors.

Lee H, Herrmann A, Deng JH, Kujawski M, Niu G, Li Z, Forman S, Jove R, Pardoll DM, Yu H.

Cancer Cell. 2009 Apr 7;15(4):283-93. doi: 10.1016/j.ccr.2009.02.015.

23.

Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy.

Kortylewski M, Kujawski M, Herrmann A, Yang C, Wang L, Liu Y, Salcedo R, Yu H.

Cancer Res. 2009 Mar 15;69(6):2497-505. doi: 10.1158/0008-5472.CAN-08-3031. Epub 2009 Mar 3.

24.

Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment.

Kortylewski M, Xin H, Kujawski M, Lee H, Liu Y, Harris T, Drake C, Pardoll D, Yu H.

Cancer Cell. 2009 Feb 3;15(2):114-23. doi: 10.1016/j.ccr.2008.12.018. Erratum in: Cancer Cell. 2010 Nov 16;18(5):536.

25.

Computer-aided applications of nanoscale smart materials for biomedical applications.

Rakesh L, Howell BA, Chai M, Mueller A, Kujawski M, Fan D, Ravi S, Slominski C.

Nanomedicine (Lond). 2008 Oct;3(5):719-39. doi: 10.2217/17435889.3.5.719. Review.

PMID:
18817472
26.

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.

Kujawski M, Kortylewski M, Lee H, Herrmann A, Kay H, Yu H.

J Clin Invest. 2008 Oct;118(10):3367-77. doi: 10.1172/JCI35213.

27.

Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells.

Niu G, Briggs J, Deng J, Ma Y, Lee H, Kortylewski M, Kujawski M, Kay H, Cress WD, Jove R, Yu H.

Mol Cancer Res. 2008 Jul;6(7):1099-105. doi: 10.1158/1541-7786.MCR-07-2177.

28.

Chromosomal gains and losses indicate oncogene and tumor suppressor gene candidates in salivary gland tumors.

Giefing M, Wierzbicka M, Rydzanicz M, Cegla R, Kujawski M, Szyfter K.

Neoplasma. 2008;55(1):55-60.

PMID:
18190242
29.

Molecular dynamics simulation of polyamidoamine dendrimer-fullerene conjugates: generations zero through four.

Kujawski M, Rakesh L, Gala K, Jensen A, Fahlman B, Feng ZR, Mohanty DK.

J Nanosci Nanotechnol. 2007 Apr-May;7(4-5):1670-4.

PMID:
17450941
30.

Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity.

Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, Pilon-Thomas S, Niu G, Kay H, Mulé J, Kerr WG, Jove R, Pardoll D, Yu H.

Nat Med. 2005 Dec;11(12):1314-21. Epub 2005 Nov 20.

PMID:
16288283
31.

Second primary tumors (SPT) of head and neck: distinguishing of "true" SPT from micrometastasis by LOH analysis of selected chromosome regions.

Giefing M, Rydzanicz M, Szukala K, Wozniak A, Wierzbicka M, Szyfter K, Kujawski M.

Neoplasma. 2005;52(5):374-80.

PMID:
16151577
32.

Synergistic and antagonistic properties of selected cultures of lactic acid and propionic acid bacteria. Part I. Fermentation activity.

Sańko B, Kujawski M, Podhajna E, Cichosz G, Butler J.

Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet. 2001;66(3b):621-5.

PMID:
15954668
33.

Synergistic and antagonistic properties of selected cultures of lactic acid and propionic acid bacteria. Part II. Proteolytic activity.

Podhajna E, Kujawski M, Sańko B, Cichosz G, Butler J.

Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet. 2001;66(3b):617-20.

PMID:
15954667
34.

CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.

Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K.

Mutat Res. 2005 Jul 1;574(1-2):112-23. Epub 2005 Apr 15.

PMID:
15914211
35.

Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects.

Burdelya L, Kujawski M, Niu G, Zhong B, Wang T, Zhang S, Kortylewski M, Shain K, Kay H, Djeu J, Dalton W, Pardoll D, Wei S, Yu H.

J Immunol. 2005 Apr 1;174(7):3925-31.

36.

Tissue factor pathway inhibitor and thrombin activatable fibrinolytic inhibitor plasma levels following burn and septic injuries in rats.

Ravindranath TM, Goto M, Demir M, Tobu M, Kujawski MF, Hoppensteadt D, Samonte V, Iqbal O, Sayeed MM, Fareed J.

Clin Appl Thromb Hemost. 2004 Oct;10(4):379-85.

PMID:
15497025
37.

[Mutagen sensitivity in patients with multiple primary tumors (MPT) of the head and neck region--quantitative and qualitative assessment based on bleomycin assay].

Wierzbicka M, Jarmuz M, Gajecka M, Kujawski M, Szyfter W, Szyfter K.

Otolaryngol Pol. 2004;58(3):441-9. Polish.

PMID:
15311585
38.

Frequent chromosome Y loss in primary, second primary and metastatic squamous cell carcinomas of the head and neck region.

Kujawski M, Jarmuz M, Rydzanicz M, Szukala K, Wierzbicka M, Grenman R, Golusinski W, Szyfter K.

Cancer Lett. 2004 May 10;208(1):95-101.

PMID:
15105051
39.

Biochemical and pharmacologic heterogeneity in low molecular weight heparins. Impact on the therapeutic profile.

Fareed J, Hoppensteadt D, Schultz C, Ma Q, Kujawski MF, Neville B, Messmore H.

Curr Pharm Des. 2004;10(9):983-99. Review.

PMID:
15078128
40.

Rearrangements involving the 13q chromosome arm committed to the progression of laryngeal squamous cell carcinoma.

Kujawski M, Rydzanicz M, Sarlomo-Rikala M, Szyfter K.

Cancer Genet Cytogenet. 2002 Aug;137(1):54-8.

PMID:
12377414
41.

Chromosome alterations reflect clonal evolution in squamous cell carcinoma of the larynx.

Kujawski M, Rydzanicz M, Sarlomo-Rikala M, Gabriel A, Szyfter K.

Med Sci Monit. 2002 Jul;8(7):BR279-82.

42.

[Chromosome damage in the course of laryngeal squamous cell carcinoma].

Szyfter K, Kujawski M, Dabrowski P, Jarmuz M, Kita S, Biegalski W, Szyfter W.

Otolaryngol Pol. 1999;53(5):533-8. Review. Polish.

PMID:
10689907
43.

Effects of phosphorolytic and cell wall-degrading enzymes on the performance of growing broilers fed wheat-based diets containing different calcium levels.

Zyla K, Koreleski J, Swiatkiewicz S, Wikiera A, Kujawski M, Piironen J, Ledoux DR.

Poult Sci. 2000 Jan;79(1):66-76.

PMID:
10685891
44.

DNA copy number losses are more frequent in primary larynx tumors with lymph node metastases than in tumors without metastases.

Kujawski M, Aalto Y, Jaskula-Sztul R, Szyfter W, Szmeja Z, Szyfter K, Knuutila S.

Cancer Genet Cytogenet. 1999 Oct 1;114(1):31-4.

PMID:
10526532
45.

Recurrent DNA copy number losses associated with metastasis of larynx carcinoma.

Kujawski M, Sarlomo-Rikala M, Gabriel A, Szyfter K, Knuutila S.

Genes Chromosomes Cancer. 1999 Nov;26(3):253-7.

PMID:
10502324
46.

Genotoxicity of inhalation anesthetics halothane and isoflurane in human lymphocytes studied in vitro using the comet assay.

Jaloszyński P, Kujawski M, Wasowicz M, Szulc R, Szyfter K.

Mutat Res. 1999 Feb 19;439(2):199-206.

PMID:
10023059
47.

[Sex-dependence of larynx susceptibility to tobacco smoke carcinogens. The role of androgen hormones].

Szyfter K, Kruk-Zagajewska A, Szmeja Z, Kozak W, Szyfter W, Kujawski M, Banaszewski J, Wójtowicz J.

Otolaryngol Pol. 1998;52(2):153-8. Polish.

PMID:
9673113
48.

Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assay.

Jałoszyński P, Kujawski M, Czub-Swierczek M, Markowska J, Szyfter K.

Mutat Res. 1997 Dec;385(3):223-33.

PMID:
9506891
49.
50.

Supplemental Content

Loading ...
Support Center